
Yair Einhorn
@yaireinhorn
Science & Innovation. Special interest in BioTech, Pharma, Gene Editing & CRISPR 🧬. Also sharing my thoughts on the Financial Markets & the Global Economy. 📈
ID: 1238780417324580867
14-03-2020 10:54:12
18,18K Tweet
13,13K Takipçi
46 Takip Edilen

1/A new & promising platform was presented at #ASGCT2023 by Penn Medicine’s Nils_Wellhausen - #EpitopeEditing. By using #BaseEditing #EpitopeEditing aims to shield hematopoietic cells from CD45-directed #immunetherapy without the loss of CD45 protein function. #BioTech #CRISPR $BEAM
